UCSF Health Reaches 20,000 Organ Transplants
UCSF surgeons have performed the health system’s 20,000th solid organ transplant, making it just the third in the nation to reach that milestone.
University of California San Francisco
Give to UCSFUCSF surgeons have performed the health system’s 20,000th solid organ transplant, making it just the third in the nation to reach that milestone.
For preteens, the odds of developing OCD over a two-year period increases for every hour they play video games or watch videos.
Researchers have engineered molecules that act like “cellular glue,” a major step toward building tissues and organs.
UCSF experts in multiple myeloma and other hematologic malignancies will attend the American Society of Hematology’s (ASH) 64th Annual Meeting and Exposition.
A new sophisticated machine learning technique using a molecular library of commands guides engineered immune cells to seek out and tirelessly kill cancer cells.
New records in the Opioid Industry Documents show that Insys Therapeutics improperly sold vast amounts of its addictive product for off-label uses.
UCSF breast cancer experts will present new research and clinical findings at the annual San Antonio Breast Cancer Symposium, the largest and most prestigious breast cancer conference.
UCSF Health and UCSF Dentistry are the first academic health system in the West to merge medical and oral health records into an electronic health record.
Stress during pregnancy can impact children’s cell aging, and race is an important factor.
Promises from companies leap ahead of medical science in promoting the use of smartwatches to screen for heart rhythm disorders says UCSF’s Gregory Marcus.
To improve assessment of patients who may be at risk for aortic dissection and rupture, researchers from UCSF researchers developed a prediction model of aortic diameter to identify asymptomatic individuals with enlarged ascending aortic diameter.
A low-cost, prenatal intervention benefits mothers’ mental health up to eight years later, a new UCSF study finds.
Researchers have identified specific immune cells that drive deadly heart inflammation in a small fraction of patients treated with powerful cancer immunotherapy drugs.
UCSF Medical Center earned its third consecutive Magnet Recognition®, representing more than a decade of gold-standard excellence in nursing and hospital practices, and quality patient care.
E-cigarettes and marijuana have similar harmful effects on the heart as tobacco cigarettes, opening the door to abnormal heart rhythms, reports a team of researchers at UCSF.
A new method of comparing massive numbers of CAR-T cells can determine which is most effective and long-lasting against cancer.
Using a protocol developed at UCSF, physicians have successfully treated a fetus with a devastating genetic disorder for the first time, and the child is now thriving as a toddler.
Bacteria in our guts may play a significant role in the metabolism of anti-cancer drugs that are critical for treating colon cancer and other types of cancers.
Immune checkpoint inhibitors (ICIs) used in cancer care can cause myocarditis, a potentially fatal side effect, and it appears that the adverse cardiac effects may disproportionally impact female patients.
A new diagnostic method that applies machine learning to advanced genomics data from both microbe and host to identify and predict sepsis cases was developed by researchers at UCSF, the Chan Zuckerberg Initiative, and CZ Biohub.
Cystic fibrosis is missed more often in newborn screenings for non-white than white babies, creating higher risk for irreversible lung damage and other serious outcomes in Black, Hispanic, Asian, American Indian and Alaska Native newborns.
Scientists at UCSF have developed a new way of looking at sex-biased diseases that is rooted in evolutionary biology.
A new UCSF study researchers of more than 23 million people concludes that some commonly used and abused drugs pose previously unidentified risks for the development of atrial fibrillation (AF), a potentially deadly heart-rhythm disorder.
A small molecule called ISRIB that was identified at UCSF can reverse the neuronal and cognitive effects of concussion in mice weeks after an injury occurred, new research found.